The authors also showed that OPG levels were elevated in the serum of patients with Hodgkin’s disease and non-Hodgkin’s lymphoma, and decreased in the serum of patients with multiple myeloma. This evidence concerns the gene TNFRSF11B and non-Hodgkin lymphoma.